Cosentyx is a biologic medication used to treat several inflammatory conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a protein called interleukin-17A, which is involved in the inflammation process [1]. According to Drug Patent Watch, the first patent for Cosentyx expired in 2032, and there are no generic versions available yet [1].

The cost of Cosentyx varies depending on the dosage, frequency of administration, and insurance coverage. The official Cosentyx website offers a cost estimator tool that helps patients estimate their out-of-pocket expenses based on their insurance plan [2]. However, even with insurance coverage, some patients may still face high costs, as biologic medications are generally more expensive than traditional drugs [3].

Despite its high cost, Cosentyx has been shown to be effective in treating psoriasis and other inflammatory conditions. In clinical trials, Cosentyx was found to be more effective than placebo in reducing the severity of psoriasis symptoms and improving patients' quality of life [1].

In conclusion, whether Cosentyx is worth the cost depends on individual circumstances, such as the severity of the condition being treated, insurance coverage, and financial resources. Patients should discuss the potential benefits and risks of Cosentyx with their healthcare provider and consider all available treatment options before making a decision.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/treatment-cost
[3] https://www.reuters.com/article/us-novartis-results/novartis-ceo-feels-heat-on-u-s-generics-cosentyx-drop-idUSKBN1HQ0IG